Company news
Suzhou Ribo Life Science Co. Ltd. Class H (HKEX:6938) news
Suzhou Ribo Life Science Co. Ltd. Class H news releases on 6ix. Latest, May 12, 2026: Ribo Announces Strategic Collaboration with Insilico Medicine…
Press releases & updates
Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI
May 12, 2026
Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)
May 6, 2026
Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH
February 11, 2026
Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange
January 9, 2026